Department of Plastic, Reconstructive and Aesthetic Surgery, Ondokuz Mayis University Medical School, Samsun, Turkey.
J Reconstr Microsurg. 2010 Feb;26(2):137-43. doi: 10.1055/s-0029-1243299. Epub 2009 Dec 10.
Although some authors previously stated that microlymphatic surgery does not have application to primary lymphedema, opposite views are reported based on the observations that the lymphatics were not hypoplastic in majority of these patients and microlymphatic surgery yielded significant improvement. The aim of this study was to compare the intraoperative findings and outcomes of primary and secondary lower-extremity lymphedema cases treated with lymphaticovenous shunts. Between December 2006 and April 2009, microlymphatic surgery was performed in 80 lower extremities with primary and 21 with secondary lymphedema. These two groups of extremities are compared according to the morphology of the lymphatic vessels and possibility of precise anastomoses, their response to the treatment, and final outcomes based on volumetric measurements during the follow-up period. The morphology of the lymphatics in secondary lymphedema was more consistent, and at least one collector larger than 0.3 mm was available for anastomosis in 20 of 21 extremities. In the primary lymphedema group, the lymphatics were smaller than 0.3 mm in 13 of 80 extremities. It was, therefore, possible to perform supermicrosurgical lymphaticovenous anastomosis in 84% of extremities with primary lymphedema and 95% of extremities with secondary lymphedema. Reduction of the edema occurred earlier in the secondary lymphedema group, but the mean reduction in the edema volume was comparable between the two groups. Microlymphatic surgery, although more effective and offered as the treatment of choice for secondary lymphedema, would also be a valuable and relevant treatment of primary lymphedema.
虽然一些作者之前曾表示,微淋巴管手术不适用于原发性淋巴水肿,但也有相反的观点,他们观察到大多数此类患者的淋巴管并没有发育不全,而且微淋巴管手术带来了显著的改善。本研究旨在比较原发性和继发性下肢淋巴水肿患者行淋巴管静脉分流术的术中发现和结果。2006 年 12 月至 2009 年 4 月,对 80 例原发性和 21 例继发性下肢淋巴水肿患者进行了微淋巴管手术。根据淋巴管的形态和精确吻合的可能性、对治疗的反应以及随访期间体积测量的最终结果,对这两组肢体进行了比较。继发性淋巴水肿的淋巴管形态更一致,21 例肢体中有 20 例至少有一条大于 0.3 毫米的收集管可用于吻合。在原发性淋巴水肿组中,80 例肢体中有 13 例的淋巴管小于 0.3 毫米。因此,84%的原发性淋巴水肿肢体和 95%的继发性淋巴水肿肢体能够进行超显微淋巴管静脉吻合术。继发性淋巴水肿组的水肿消退较早,但两组的平均水肿体积减少相当。虽然微淋巴管手术对继发性淋巴水肿更有效,且是其治疗的首选,但对原发性淋巴水肿也是一种有价值和相关的治疗方法。